BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3010783)

  • 1. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Jun; 104(6):824-5. PubMed ID: 3010783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Apr; 35(14):221-3. PubMed ID: 3007970
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupational risk of the acquired immunodeficiency syndrome among health care workers.
    McCray E
    N Engl J Med; 1986 Apr; 314(17):1127-32. PubMed ID: 3485769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(45):681-6, 691-5. PubMed ID: 2997587
    [No Abstract]   [Full Text] [Related]  

  • 9. CDC recommendations for preventing transmission of AIDS during invasive procedures.
    Tex Nurs; 1986 Aug; 60(7):14. PubMed ID: 3018952
    [No Abstract]   [Full Text] [Related]  

  • 10. Leads from the MMWR. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures.
    JAMA; 1986 Sep; 256(10):1257, 1262. PubMed ID: 3018303
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.
    Ann Intern Med; 1986 Aug; 105(2):234-7. PubMed ID: 3014942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal precautions: CDC perspective.
    Hughes JM
    Occup Med; 1989; 4 Suppl():13-20. PubMed ID: 2545005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal precautions to prevent HIV transmission to health care workers: an economic analysis.
    Stock SR; Gafni A; Bloch RF
    CMAJ; 1990 May; 142(9):937-46. PubMed ID: 2158390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of human immunodeficiency virus (HIV) in health-care settings worldwide.
    Marcus R; Kay K; Mann JM
    Bull World Health Organ; 1989; 67(5):577-82. PubMed ID: 2692871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update: prospective evaluation of health-care workers exposed via the parenteral or mucous-membrane route to blood or body fluids from patients with acquired immunodeficiency syndrome--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):101-3. PubMed ID: 3918247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Sep; 103(3):402-3. PubMed ID: 2992336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second meeting of the WHO Collaborating Centres on AIDS: Memorandum from a WHO meeting.
    Bull World Health Organ; 1986; 64(1):37-46. PubMed ID: 3015444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for preventing transmission of HIV in health care settings.
    CMAJ; 1988 Feb; 138(3):213-9. PubMed ID: 2827876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.